Nuwellis Accelerates Digital Transformation of the Aquadex® Platform with EHR Connectivity and Enhanced User Interface

MINNEAPOLIS, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced a digital transformation program designed to position the Aquadex SmartFlow(®) System as a connected extracorporeal therapy platform for the modern intensive care environment. The program includes integration through Philips Capsule(™) medical device interoperability technology and development of a next-generation tablet-based user interface. Together, these enhancements are expected to improve clinical workflow, strengthen interoperability with hospital information systems, and establish the digital foundation for future software-enabled innovations across the Aquadex platform.

The development program consists of two complementary initiatives. The first will integrate the Aquadex platform with leading electronic health record (EHR) systems, enabling therapy data generated during Aquadex treatments to be automatically transmitted into a patient's electronic medical record. The second initiative introduces a modern tablet-based user interface that will display key therapy information and device status in an intuitive, streamlined format designed to improve clinician workflow and ease of use. The digital architecture being developed is also expected to support future software-enabled decision support and advanced analytics capabilities as the platform evolves.